The Effect of Ratio of Kidney Weight to Recipient Weight and Body Surface Area on the Renal Allograft Outcome.
- Author:
Tae Seung LEE
1
;
In Mok JUNG
;
Byung Sun CHO
;
Jong Won HA
;
Sang Joon KIM
Author Information
1. Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Hyperfiltration injury;
Kidney size;
Renal transplantation
- MeSH:
Allografts*;
Body Surface Area*;
Cadaver;
Creatinine;
Female;
Follow-Up Studies;
Humans;
Hypertrophy;
Kidney Transplantation;
Kidney*;
Living Donors;
Male;
Nephrons;
Proteinuria;
Tissue Donors;
Transplants
- From:The Journal of the Korean Society for Transplantation
1997;11(2):247-252
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The hyperfiltration hypothesis postulates that kidney with reduced renal mass will progress toward failure due to hypertrophy of the remaining nephron to meet the excess load, eventually leading to nephron exhaustion. We assessed the influence of renal size on graft function in all allogrft except loss of graft within 6 month between September 1995 and February 1997(n=58). Patients were divided into two groups based on the ratio of kidney weight to recipient body surface area(KW/BSA>or=0.11, KW/BSA<0.11), weight(KW/BW>or=0.3, KW/BW<0.3) respectively and outcomes were compared by methods including student t-test and Chi-square test. Three conditions, in which hyperfiltration might be suspected, proposed by Teraski, were studied also: grafts from females to males compared with males to females, kidneys that experience rejection episodes and cadaveric grafts compared with living donor grafts. There was no correlation between KW/BSA, KW/BW and serum creatinine and degree of proteinuria at 1, 3, 6, 12 months posttransplant. Three conditions under which hyperfiltration damage might be suspected had no differences in study groups. Although more cases should be studied with long term follow-up, we conclude that donor kidney size has no apparent effect on renal allograft outcome in short term follow-up.